Back

Trends in P2Y12 inhibitor use after acute coronary syndromes: insights from the ProACS registry

1 September 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Thrombosis, platelets, and coagulation in coronary disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ana Ines Aguiar Neves

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor M. Camera (Milan, IT)
Abstract
Presentation thumbnail
Mr H. Nohara (Sakai, JP)
Abstract Slides Video
Presentation thumbnail
Doctor A. Del Torto (Milano, IT)
Abstract Slides Video
Presentation thumbnail
Doctor P. Meunier (Montpellier, FR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Thrombosis, platelets, and coagulation in coronary disease

The Event

Event poster

ESC Congress 2025

1 September 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Comparative effectiveness of prasugrel and ticagrelor among patients undergoing contemporary PCI: insights from the BMC2 registry
thumbnail
Congress Presentation
Prognostic implications of p2y12 inhibitor pre-treatment in non-st segment elevation acute coronary syndromes undergoing late invasive strategy - a national registry analysis
thumbnail
Congress Presentation
Association of P2Y12 inhibitor pretreatment strategy with short and long term ischemic and bleeding outcomes in NSTE-ACS patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources